Value accretive shift in strategy. Directed share issue of SEK 150m. Fair value range up to SEK 9-15 (from 6-15).
27 Sep 2023
Becoming a pure play on orthobiologics
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Becoming a pure play on orthobiologics
- Published:
27 Sep 2023 -
Author:
ABGSC Healthcare Research | Sten Gustafsson -
Pages:
11 -
Value accretive shift in strategy. Directed share issue of SEK 150m. Fair value range up to SEK 9-15 (from 6-15).